Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Escalation of conflict with Hezbollah triggers forest fires in Northern Israel On Tuesday, June 4, a serious escalation in the ongoing conflict between Lebanon-backed Hezbollah and Israel led to… byPallavi MadhirajuJune 5, 2024